Harel Insurance Investments & Financial Services Ltd. Boosts Holdings in Chemed Corporation $CHE

Harel Insurance Investments & Financial Services Ltd. boosted its position in shares of Chemed Corporation (NYSE:CHE) by 113.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 20,009 shares of the company’s stock after acquiring an additional 10,635 shares during the period. Harel Insurance Investments & Financial Services Ltd.’s holdings in Chemed were worth $8,561,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Alps Advisors Inc. lifted its position in Chemed by 32.4% during the third quarter. Alps Advisors Inc. now owns 44,295 shares of the company’s stock valued at $19,833,000 after acquiring an additional 10,845 shares during the last quarter. Vest Financial LLC lifted its position in Chemed by 32.6% during the third quarter. Vest Financial LLC now owns 9,702 shares of the company’s stock valued at $4,344,000 after acquiring an additional 2,383 shares during the last quarter. SG Americas Securities LLC lifted its position in Chemed by 773.5% during the fourth quarter. SG Americas Securities LLC now owns 26,466 shares of the company’s stock valued at $11,324,000 after acquiring an additional 23,436 shares during the last quarter. Van Berkom & Associates Inc. lifted its position in Chemed by 33.0% during the third quarter. Van Berkom & Associates Inc. now owns 170,813 shares of the company’s stock valued at $76,480,000 after acquiring an additional 42,390 shares during the last quarter. Finally, Envestnet Asset Management Inc. lifted its position in Chemed by 6.5% during the third quarter. Envestnet Asset Management Inc. now owns 80,080 shares of the company’s stock valued at $35,855,000 after acquiring an additional 4,865 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the transaction, the chief executive officer owned 90,219 shares of the company’s stock, valued at approximately $37,993,927.47. The trade was a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 3.33% of the company’s stock.

Chemed Stock Up 0.5%

CHE opened at $427.85 on Wednesday. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $583.96. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. The company has a fifty day moving average of $398.34 and a two-hundred day moving average of $425.88. The stock has a market capitalization of $5.68 billion, a price-to-earnings ratio of 23.32, a PEG ratio of 1.60 and a beta of 0.54.

Chemed (NYSE:CHE) last released its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, beating analysts’ consensus estimates of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The company had revenue of $657.51 million during the quarter, compared to analysts’ expectations of $659.22 million. During the same quarter in the previous year, the company earned $5.63 earnings per share. The firm’s revenue for the quarter was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, research analysts expect that Chemed Corporation will post 22.3 earnings per share for the current year.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Monday, February 23rd were issued a $0.60 dividend. The ex-dividend date of this dividend was Monday, February 23rd. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. Chemed’s payout ratio is presently 13.08%.

Analyst Ratings Changes

A number of research firms recently commented on CHE. Wall Street Zen raised shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday. Oppenheimer decreased their target price on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research report on Friday, February 27th. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Royal Bank Of Canada raised their price target on shares of Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a report on Monday, April 27th. Finally, Jefferies Financial Group cut shares of Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Two investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Chemed has an average rating of “Hold” and an average target price of $501.50.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.